nafamostat has been researched along with Ischemia in 10 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gobbetti, T | 1 |
| Cenac, N | 1 |
| Motta, JP | 1 |
| Rolland, C | 1 |
| Martin, L | 1 |
| Andrade-Gordon, P | 1 |
| Steinhoff, M | 1 |
| Barocelli, E | 1 |
| Vergnolle, N | 1 |
| Chang, M | 1 |
| Alsaigh, T | 1 |
| Kistler, EB | 3 |
| Schmid-Schönbein, GW | 5 |
| Ishimaru, K | 1 |
| Mitsuoka, H | 3 |
| Unno, N | 1 |
| Inuzuka, K | 1 |
| Nakamura, S | 1 |
| Ihno, T | 1 |
| Nakagawa, T | 1 |
| Furukawa, H | 1 |
| Shimizu, K | 1 |
| Egi, K | 1 |
| Maemura, T | 1 |
| Motomiya, T | 1 |
| Kimura, T | 1 |
| Andoh, A | 1 |
| Fujiyama, Y | 1 |
| Saotome, T | 1 |
| Bamba, T | 1 |
| Kizaki, Y | 1 |
| Ueki, Y | 1 |
| Yoshida, K | 1 |
| Yano, M | 1 |
| Matsumoto, K | 1 |
| Miyake, S | 1 |
| Tominaga, Y | 1 |
| Eguchi, K | 1 |
| Yano, K | 1 |
| Lefer, AM | 1 |
| Hugli, TE | 1 |
| Kuratani, T | 1 |
| Matsuda, H | 1 |
| Sawa, Y | 1 |
| Kaneko, M | 1 |
| Nakano, S | 1 |
| Kawashima, Y | 1 |
10 other studies available for nafamostat and Ischemia
| Article | Year |
|---|---|
Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.
Topics: alpha-Macroglobulins; Animals; Benzamidines; Chemokines; Cysteine Proteinase Inhibitors; Granulocyte | 2012 |
Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine.
Topics: Acarbose; Amylases; Animals; Benzamidines; Cadherins; Cell Line; Dextrans; Diffusion; Epithelial Cel | 2012 |
Pancreatic proteases and inflammatory mediators in peritoneal fluid during splanchnic arterial occlusion and reperfusion.
Topics: Animals; Arteries; Benzamidines; Blood Pressure; Cardiovascular System; Endopeptidases; Enzyme Inhib | 2004 |
Various problems during long-term percutaneous cardiopulmonary support.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Benzamidines; Blood Transfusion, Autologous; Cardiop | 1997 |
A blockade of complement activation prevents rapid intestinal ischaemia-reperfusion injury by modulating mucosal mast cell degranulation in rats.
Topics: Anaphylatoxins; Animals; Benzamidines; Cell Degranulation; Cell Membrane Permeability; Chelating Age | 1998 |
Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Benzamidines; Blood Component Removal; Bradykinin | 1999 |
Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes.
Topics: Animals; Benzamidines; Bile; Blood Pressure; Guanidines; Intestinal Mucosa; Intestines; Ischemia; Le | 2000 |
Plasma activation during splanchnic arterial occlusion shock.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Benzamidines; Biological Factors; Cats; Celiac | 2000 |
Mechanisms for blockade of in vivo activator production in the ischemic intestine and multi-organ failure.
Topics: Allopurinol; Animals; Benzamidines; Bile; Blood Pressure; Duodenum; Guanidines; Intestinal Mucosa; I | 2000 |
Experimental study in a rabbit model of ischemia-reperfusion lung injury during cardiopulmonary bypass.
Topics: Adenosine Triphosphate; Animals; Benzamidines; Blood; Cardiopulmonary Bypass; Constriction; Guanidin | 1992 |